Log In
Print
BCIQ
Print
Print this Print this
 

OCA, obeticholic acid (DSP-1747) (formerly 6ECDCA, INT-747)

  Manage Alerts
Collapse Summary General Information
Company Intercept Pharmaceuticals Inc.
DescriptionOral farnesoid X receptor (FXR; NR1H4) agonist
Molecular Target Farnesoid X receptor (FXR) (NR1H4)
Mechanism of ActionFarnesoid X receptor agonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$315.0M

$15.0M

$300.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today